Reuters logo
4 个月前
BRIEF-Immunomedics reports preclinical study presented at 2017 AACR annual meeting
2017年4月4日 / 下午12点32分 / 4 个月前

BRIEF-Immunomedics reports preclinical study presented at 2017 AACR annual meeting

1 分钟阅读

April 4 (Reuters) - Immunomedics Inc:

* Immunomedics reports immu-132 delivers high levels of sn-38 that overcome chemoresistant tumors with moderate to strong trop-2 expression Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below